Available exclusively through NWL in the UK, NeuterReady provides a structured way to support clinical decision-making prior to neutering procedures, helping bring greater consistency to how diagnostics are used in routine care.

Developed to fit naturally into practice workflows, NeuterReady is designed to make diagnostics before neutering easier to implement—supporting teams with a clear, repeatable approach rather than adding complexity.

With a simple, accessible price point of £45 per test, NeuterReady offers a practical way for practices to introduce or standardise diagnostics before neutering as part of routine care.

Importantly, practices do not need to move all of their diagnostic work to NWL to use NeuterReady. Many introduce it alongside their existing laboratory arrangements, making it a straightforward option to trial and embed within current processes.

As part of NVS Group, NWL combines diagnostic expertise with the strength of the wider NVS infrastructure, including:

• Reliable sample collection supported by the NVS logistics network
• UK-based laboratory services
• Access to pathologists when clinical input is required

At BVA Live, visitors will have the opportunity to learn more about how NeuterReady works in practice and explore how a more structured approach to diagnostics can support consistency across the clinical team.